Objective: To illustrate interactions among moleculars, targets and diseases using network
pharmacology and to explore the efficacy materials and mechanism of Ganfule (GFL) …

Liver cancer (LC), a frequently occurring cancer, has become the fourth leading cause of
cancer mortality. The small number of reported data and diverse spectra of …

Background: Hepatocellular carcinoma (HCC) is a malignant tumor harmful to human
health. Ganji Fang (GJF) has good clinical efficacy in the treatment of HCC, but its …

Objective: To predict and analyze the target of anti-Hepatocellular Carcinoma (HCC) in the
active constituents of Safflower by using network pharmacology. Methods: The active …

Hepatocellular carcinoma (HCC) is the sixth most common type of cancer in the world. It is
the third leading cause of cancer-related mortality. In more than 80% of people liver cancer …

Hepatocellular carcinoma (HCC) is a complex and refractory malignant tumor, ranking the
third cause of cancer‐related deaths worldwide. Lenvatinib is currently employed to treat …

Objective: This paper aims to explore the potential anti-neoplasm targets and mechanism of
Danggui Sinitang on hepatocellular carcinoma by analyzing the prescription of Danggui …

Objectives To explore gingerol's potential mechanism for treating liver cancer using network
pharmacology and molecular docking technology and to conduct in-vitro experiments of …

Background Galangin, a flavonoid compound, is derived from Alpinia officinarum Hance.
Previous studies have shown that galangin can inhibit the proliferation of hepatocellular …

As one of the most common malignant tumors, hepatocellular carcinoma (HCC) has a rising
incidence rate and also seriously endangers human life and health. According to research …